The synergistic roles of cholecystokinin B and dopamine D5 receptors on the regulation of excretion

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Jiang, Xiaoliang ^a   Chen, Wei ^a   Liu, Xing ^a   Wang, Zihao ^a   Liu, Yunpeng ^a   Felder, Robin A ^b   Gildea, John J ^b   Jose, Pedro A ^c   Qin, Chuan ^a   Yang, Zhiwei ^a,d  

^a INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d Beijing Collaborative Innovation Center for Cardiovascular Disorders   (China)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; CHOLECYSTOKININ; CHOLECYSTOKININ B; CHOLECYSTOKININ B RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 5 RECEPTOR; FENOLDOPAM; GASTRIN; SODIUM; UNCLASSIFIED DRUG; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BENZAZEPINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DIURESIS; DRUG MECHANISM; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPERTENSION; IMMUNOPRECIPITATION; KIDNEY; KIDNEY CORTEX; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NATRIURESIS; NONHUMAN; PROTEIN EXPRESSION; SODIUM BALANCE; SODIUM EXCRETION; SODIUM INTAKE; SODIUM RESTRICTION; SODIUM URINE LEVEL; ANIMAL; BAGG ALBINO MOUSE; BLOOD PRESSURE; CHEMISTRY; FEMALE; GENE EXPRESSION REGULATION; HEK293 CELL LINE; KIDNEY TUBULE; METABOLISM; TRANSGENIC MOUSE;

ANIMALS; BENZAZEPINES; BLOOD PRESSURE; CHOLECYSTOKININ; FEMALE; FENOLDOPAM; GASTRINS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; KIDNEY; KIDNEY TUBULES; MALE; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NATRIURESIS; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, DOPAMINE D5; SODIUM;

EID: 84954535739     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146641     Document Type: Article

References (71)

1. Liang M, Cowley AW Jr, Mattson DL, Kotchen TA, Liu Y. (2013) Epigenomics of hypertension. Semin Nephrol 33:392-399. doi: 10.1016/j.semnephrol.2013.05.011 PMID: 24011581
2. Forman JP, Scheven L, de Jong PE, Bakker SJ, Curhan GC, Gansevoort RT. (2012) Association between sodium intake and change in uric acid, urine albumin excretion, and the risk of developing hypertension. Circulation 125:3108-3116. doi: 10.1161/CIRCULATIONAHA.112.096115 PMID: 22711274
3. Mente A, O'Donnell MJ, Rangarajan S, McQueen MJ, Poirier P, Wielgosz A, et al. (2014) Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med 371:601-611. doi: 10.1056/NEJMoa1311989 PMID: 25119606
4. Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerova J, Richart T, et al. (2011) Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA 305:1777-1785. doi: 10.1001/jama.2011.574 PMID: 21540421
5. O'Donnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, et al. (2014) Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med 371:612-623. doi: 10.1056/NEJMoa1311889 PMID: 25119607
6. Herrera M, Coffman TM. (2012) The kidney and hypertension: Novel insights from transgenic models. Curr Opin Nephrol Hypertens 21:171-178. doi: 10.1097/MNH.0b013e3283503068 PMID: 22274801
7. Hamlyn JM. (2014) Natriuretic hormones, endogenous ouabain, and related sodium transport inhibitors. Front Endocrinol (Lausanne) 5:199.
8. Hussain T, Lokhandwala MF. (2003) Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 228:134-142.
9. Zhang MZ, Harris RC. (2015) Antihypertensive mechanisms of intra-renal dopamine. Curr Opin Nephrol Hypertens 24:117-122. doi: 10.1097/MNH.0000000000000104 PMID: 25594544
10. Sanada H, Jones JE, Jose PA. (2011) Genetics of salt-sensitive hypertension. Curr Hypertens Rep 13:55-66. doi: 10.1007/s11906-010-0167-6 PMID: 21058046
11. Weder AB, Gleiberman L, Sachdeva A. (2009) Urinary dopamine excretion and renal responses to fenoldopam infusion in blacks and whites. J Clin Hypertens (Greenwich) 11:707-712.
12. Salomone LJ, Howell NL, McGrath HE, Kemp BA, Keller SR, Gildea JJ, et al. (2007) Intrarenal dopamine D1-like receptor stimulation induces natriuresis via an angiotensin type-2 receptor mechanism. Hypertension 49:155-161. PMID: 17116755
13. Trivedi M, Marwaha A, Lokhandwala M. (2004) Rosiglitazone restores g-protein coupling, recruitment, and function of renal dopamine D1A receptor in obese Zucker rats. Hypertension 43:376-382. PMID: 14718363
14. Chen Y, Asico LD, Zheng S, Villar VA, He D, Zhou L, et al. (2013) Gastrin and D1 dopamine receptor interact to induce natriuresis and diuresis. Hypertension 62:927-933. doi: 10.1161/HYPERTENSIONAHA.113.01094 PMID: 24019399
15. Jiang X, Wang W, Ning B, Liu X, Gong J, Gan F, et al. (2013) Basal and postprandial serum levels of gastrin in normotensive and hypertensive adults. Clin Exp Hypertens 35:74-78. doi: 10.3109/10641963.2012.690474 PMID: 22680232
16. Carey RM. (1978) Evidence for a splanchnic sodium input monitor regulating renal sodium excretion in man. Lack of dependence upon aldosterone. Circ Res 43:19-23. PMID: 657455
17. Michell AR, Debnam ES, Unwin RJ. (2008) Regulation of renal function by the gastrointestinal tract: Potential role of gut-derived peptides and hormones. Annu Rev Physiol 70:379-403. PMID: 17988205
18. Tarasova NI, Kopp JA, Jose P, Farnsworth DW, Michejda CJ, Wank SA. (1996) Postprandial changes in renal function are mediated by elevated serum gastrin acting at cholecystokinin type B receptors (CCKBR) in the kidney. Gastroenterology 110:A1106-A1106.
19. Liu T, Jose PA. (2013) Gastrin induces sodium-hydrogen exchanger 3 phosphorylation and mTOR activation via a phosphoinositide 3-kinase-/protein kinase C dependent but AKT-independent pathway in renal proximal tubule cells derived from a normotensive male human. Endocrinology 154:865-875. doi: 10.1210/en.2012-1813 PMID: 23275470
20. von Schrenck T, Ahrens M, de Weerth A, Bobrowski C, Wolf G, Jonas L, et al. (2000) CCKB/gastrin receptors mediate changes in sodium and potassium absorption in the isolated perfused rat kidney. Kidney Int 58:995-1003. PMID: 10972664
21. de Weerth A, Jonas L, Schade R, Schoneberg T, Wolf G, Pace A, et al. (1998) Gastrin/cholecystokinin type B receptors in the kidney: Molecular, pharmacological, functional characterization, and localization. Eur J Clin Invest 28:592-601. PMID: 9726041
22. Melis M, Krenning EP, Bernard BF, de Visser M, Rolleman E, de Jong M. (2007) Renal uptake and retention of radiolabeled somatostatin, bombesin, neurotensin, minigastrin and cck analogues: Species and gender differences. Nucl Med Biol 34:633-641. PMID: 17707803
23. Gildea JJ, Shah IT, Van Sciver RE, Israel JA, Enzensperger C, McGrath HE, et al. (2014) The cooperative roles of the dopamine receptors, D1R and D5R, on the regulation of renal sodium transport. Kidney Int 86:118-126. doi: 10.1038/ki.2014.5 PMID: 24552847
24. Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G, et al. (1991) Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 350:614-619. PMID: 1826762
25. Tiberi M, Caron MG. (1994) High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J Biol Chem 269: 27925-27931. PMID: 7525564
26. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Bai RK, et al. (2005) D5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol 288:H55-H61. PMID: 15598876
27. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS, et al. (2006) D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol 290:R96-R104. PMID: 16352863
28. Sanada H, Jose PA, Hazen-Martin D, Yu PY, Xu J, Bruns DE, et al. (1999) Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 33:1036-1042. PMID: 10205244
29. Bavithra S, Selvakumar K, Pratheepa Kumari R, Krishnamoorthy G, Venkataraman P, Arunakaran J. (2012) Polychlorinated biphenyl (PCBs)-induced oxidative stress plays a critical role on cerebellar dopaminergic receptor expression: ameliorative role of quercetin. Neurotox Res 21:149-159. doi: 10.1007/s12640-011-9253-z PMID: 21748531
30. Ma J, Dankulich-Nagrudny L, Lowe G. (2013) Cholecystokinin: an excitatory modulator of mitral/tufted cells in the mouse olfactory bulb. PLoS One 8: e64170. doi: 10.1371/journal.pone.0064170 PMID: 23691163
31. Livak KJ, Schmittgen TD. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta c(T)) method. Methods 25:402-408. PMID: 11846609
32. Goetze JP, Eiland S, Svendsen LB, Vainer B, Hannibal J, Rehfeld JF. (2013) Characterization of gastrins and their receptor in solid human gastric adenocarcinomas. Scand J Gastroenterol 48:688-695. doi: 10.3109/00365521.2013.783101 PMID: 23544442
33. Gildea JJ, Wang X, Jose PA, Felder RA. (2008) Differential D1 and D5 receptor regulation and degradation of the angiotensin type 1 receptor. Hypertension 51:360-366. doi: 10.1161/HYPERTENSIONAHA.107.100099 PMID: 18172057
34. Mizuta K, Zhang Y, Xu D, Mizuta F, D'Ovidio F, Masaki E, et al. (2013) The dopamine D1 receptor is expressed and facilitates relaxation in airway smooth muscle. Respir Res 14:89. doi: 10.1186/1465-9921-14-89 PMID: 24004608
35. Li H, Armando I, Yu P, Escano C, Mueller SC, Asico L, et al. (2008) Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J Clin Invest 118:2180-2189. doi: 10.1172/JCI33637 PMID: 18464932
36. Takinami Y, Yuki H, Nishida A, Akuzawa S, Uchida A, Takemoto Y, et al. (1997) YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo. Aliment Pharmacol Ther 11:113-120. PMID: 9042983
37. Sordal O, Waldum H, Nordrum IS, Boyce M, Bergh K, Munkvold B, et al. (2013) The gastrin receptor antagonist netazepide (YF476) prevents oxyntic mucosal inflammation induced by Helicobacter pylori infection in Mongolian gerbils. Helicobacter 18:397-405. doi: 10.1111/hel.12066 PMID: 23865485
38. Beyer C. (1993) Creatine measurement in serum and urine with an automated enzymatic method. Clinical chemistry 39:1613-1619. PMID: 8353946
39. Atwood BK, Lopez J, Wager-Miller J, Mackie K, Straiker A. (2011) Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis. BMC Genomics 12:14. doi: 10.1186/1471-2164-12-14 PMID: 21214938
40. Asico L, Zhang X, Jiang J, Cabrera D, Escano CS, Sibley DR, et al. (2011) Lack of renal dopamine D5 receptors promotes hypertension. J Am Soc Nephrol 22:82-89. doi: 10.1681/ASN.2010050533 PMID: 21051739
41. Dahl LK, Heine M, Thompson K. (1972) Genetic influence of renal homografts on the blood pressure of rats from different strains. Proc Soc Exp Biol Med 140:852-856. PMID: 4556998
42. Coffman TM. (2014) The inextricable role of the kidney in hypertension. J Clin Invest 124:2341-2347. doi: 10.1172/JCI72274 PMID: 24892708
43. Hall JE, Granger JP, do Carmo JM, da Silva AA, Dubinion J, George E, et al. (2012) Hypertension: physiology and pathophysiology. Compr Physiol 2:2393-2442. doi: 10.1002/cphy.c110058 PMID: 23720252
44. Zhuo JL, Li XC. (2013) Proximal nephron. Compr Physiol 3:1079-1123. doi: 10.1002/cphy.c110061 PMID: 23897681
45. Zeng C, Yang Z, Wang Z, Jones J, Wang X, Altea J, et al. (2005) Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension 45:804-810. PMID: 15699451
46. Zhang L, Guo F, Guo H, Wang H, Zhang Z, Liu X, et al. (2010) The paradox of dopamine and angiotensin II-mediated Na(+), K(+)-ATPase regulation in renal proximal tubules. Clin Exp Hypertens 32:464-468. doi: 10.3109/10641963.2010.496516 PMID: 21029011
47. Gildea JJ, Wang X, Shah N, Tran H, Spinosa M, Van Sciver R, et al. (2012) Dopamine and angiotensin type 2 receptors cooperatively inhibit sodium transport in human renal proximal tubule cells. Hypertension 60:396-403. doi: 10.1161/HYPERTENSIONAHA.112.194175 PMID: 22710646
48. Aperia A. (2012) 2011 Homer Smith Award: To serve and protect: classic and novel roles for Na+, K+ -adenosine triphosphatase. J Am Soc Nephrol 23:1283-1290. doi: 10.1681/ASN.2012010102 PMID: 22745476
49. Sharon P, Karmeli F, Rachmilewitz D. (1981) PGE2 mediates the effect of pentagastrin on intestinal adenylate cyclase and Na-K-ATPase activities. Prostaglandins 21 Suppl:81-87. PMID: 6272372
50. Kopin AS, Lee YM, McBride EW, Miller LJ, Lu M, Lin HY, et al. (1992) Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA 89:3605-3609. PMID: 1373504
51. Wank SA, Harkins R, Jensen RT, Shapira H, de Weerth A, Slattery T. (1992) Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci USA 89:3125-3129. PMID: 1313582
52. Wank SA, Pisegna JR, de Weerth A. (1992) Brain and gastrointestinal cholecystokinin receptor family: Structure and functional expression. Proc Natl Acad Sci USA 89:8691-8695. PMID: 1528881
53. Ewart HS, Klip A. (1995) Hormonal regulation of the Na(+)-K(+)-atpase: Mechanisms underlying rapid and sustained changes in pump activity. Am J Physiol 269:C295-C311. PMID: 7653511
54. Bastie MJ, Delvaux M, Dufresne M, Saunier-Blache JS, Vaysse N, Ribet A. (1988) Distinct activation of Na+-H+ exchange by gastrin and CCK peptide in acini from guinea pig. Am J Physiol 254:G25-G32. PMID: 2447799
55. Delvaux M, Bastie MJ, Chentoufi J, Cragoe EJ Jr, Vaysse N, Ribet A. (1990) Amiloride and analogues inhibit Na(+)-H+ exchange and cell proliferation in AR42J pancreatic cell line. Am J Physiol 259:G842-G849. PMID: 2173418
56. Brown DA, Melvin JE, Yule DI. (2003) Critical role for NHE1 in intracellular pH regulation in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol 285:G804-G812. PMID: 12842825
57. Ahn W, Kim KH, Lee JA, Kim JY, Choi JY, Moe OW, et al. (2001) Regulatory interaction between the cystic fibrosis transmembrane conductance regulator and HCO3-salvage mechanisms in model systems and the mouse pancreatic duct. J Biol Chem 276:17236-17243. PMID: 11278980
58. Zeng C, Armando I, Luo Y, Eisner GM, Felder RA, Jose PA. (2008) Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: Studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol 294:H551-H569. PMID: 18083900
59. Zhang MZ, Yao B, Wang S, Fan X, Wu G, Yang H, et al. (2011) Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice. J Clin Invest 121:2845-2854. doi: 10.1172/JCI57324 PMID: 21701066
60. Zhang YR, Yuan ZY. (2010) Dopamine-mediated inhibition of renal Na+/K+-atpase in HK-2 cells is reduced by ouabain. Clin Exp Pharmacol Physiol 37:613-618. doi: 10.1111/j.1440-1681.2010.05364.x PMID: 20132239
61. Gildea JJ, Shah I, Weiss R, Casscells ND, McGrath HE, Zhang J, et al. (2010) HK-2 human renal proximal tubule cells as a model for G protein-coupled receptor kinase type 4-mediated dopamine 1 receptor uncoupling. Hypertension 56:505-511. doi: 10.1161/HYPERTENSIONAHA.110.152256 PMID: 20660820
62. Zhang Y, Yuan Z, Ge H, Ren Y. (2010) Effects of long-term ouabain treatment on blood pressure, sodium excretion, and renal dopamine D(1) receptor levels in rats. J Comp Physiol B 180:117-124. doi: 10.1007/s00360-009-0391-z PMID: 19626329
63. Periyasamy SM, Liu J, Tanta F, Kabak B, Wakefield B, Malhotra D, et al. (2005) Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells. Kidney Int 67:1868-1877. PMID: 15840034
64. Hollon TR, Bek MJ, Lachowicz JE, Ariano MA, Mezey E, Ramachandran R, et al. (2002) Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 22:10801-10810. PMID: 12486173
65. Ericsson P, Hakanson R, Rehfeld JF, Norlen P. (2010) Gastrin release: Antrum microdialysis reveals a complex neural control. Regul Pept 161:22-32. doi: 10.1016/j.regpep.2010.01.004 PMID: 20085791
66. McQuarrie EP, Traynor JP, Taylor AH, Freel EM, Fox JG, Jardine AG, et al. (2014) Association between urinary sodium, creatinine, albumin, and long-term survival in chronic kidney disease. Hypertension 64:111-117. doi: 10.1161/HYPERTENSIONAHA.113.03093 PMID: 24732890
67. Grimes CA, Riddell LJ, Campbell KJ, Nowson CA. (2013) Dietary salt intake, sugar-sweetened beverage consumption, and obesity risk. Pediatrics 131:14-21. doi: 10.1542/peds.2012-1628 PMID: 23230077
68. Larsen SC, Ängquist L, Sørensen TI, Heitmann BL. (2013) 24h urinary sodium excretion and subsequent change in weight, waist circumference and body composition. PLoS One 8:e69689. doi: 10.1371/journal.pone.0069689 PMID: 23936079
69. Wang X, Luo Y, Escano CS, Yang Z, Asico L, Li H, et al. (2010) Upregulation of renal sodium transporters in d5 dopamine receptor-deficient mice. Hypertension 55:1431-1437. doi: 10.1161/HYPERTENSIONAHA.109.148643 PMID: 20404220
70. Rusk IN, Cooper SJ. (1989) The selective dopamine D1 receptor agonist SK&F 38393: its effects on palatability- and deprivation-induced feeding, and operant responding for food. Pharmacol Biochem Behav 34:17-22. PMID: 2576310
71. Garlicki J, Konturek PK, Majka J, Kwiecien N, Konturek SJ. (1990) Cholecystokinin receptors and vagal nerves in control of food intake in rats. Am J Physiol 258: E40-45. PMID: 2301570